Difficulty: Medium
Average Score: 71%
Practice
Which type of leukemia has been MOST likely developed in a 2-year-old child with Down syndrome in the neonatal period?
Correct answer
D
Rationale
The correct answer is D) AML M6.
In the context of a 2-year-old child with Down syndrome in the neonatal period, the most likely type of leukemia to develop would be Acute Myeloid Leukemia (AML) M6. This is due to the increased risk of leukemia in children with Down syndrome, with AML being more common than Acute Lymphoblastic Leukemia (ALL) in this population.
Option A) ALL is less likely in this scenario as AML is more common in children with Down syndrome.
Option B) Chronic Myeloid Leukemia (CML) is a rare diagnosis in children, especially in the neonatal period.
Option C) AML M1 is less likely as AML M6 is more common in children with Down syndrome and presents with a distinct clinical and morphological profile.
Educationally, this question highlights the association between Down syndrome and leukemia, emphasizing the importance of recognizing specific leukemia subtypes in pediatric patients with genetic conditions. Understanding these associations can aid in early diagnosis and appropriate management of pediatric patients with complex medical conditions.
In the context of a 2-year-old child with Down syndrome in the neonatal period, the most likely type of leukemia to develop would be Acute Myeloid Leukemia (AML) M6. This is due to the increased risk of leukemia in children with Down syndrome, with AML being more common than Acute Lymphoblastic Leukemia (ALL) in this population.
Option A) ALL is less likely in this scenario as AML is more common in children with Down syndrome.
Option B) Chronic Myeloid Leukemia (CML) is a rare diagnosis in children, especially in the neonatal period.
Option C) AML M1 is less likely as AML M6 is more common in children with Down syndrome and presents with a distinct clinical and morphological profile.
Educationally, this question highlights the association between Down syndrome and leukemia, emphasizing the importance of recognizing specific leukemia subtypes in pediatric patients with genetic conditions. Understanding these associations can aid in early diagnosis and appropriate management of pediatric patients with complex medical conditions.